XML 31 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries

Subsidiary

 

Field of Business

 

Lineage
Ownership

 

Country

Cell Cure Neurosciences Ltd.

 

Manufacturing of Lineage’s product candidates

 

94%(1)

 

Israel

ES Cell International Pte. Ltd.

 

Research and clinical grade cell lines

 

100%

 

Singapore

 

(1)
Includes shares owned by Lineage and ES Cell International Pte. Ltd.